Ensuring safe foods and medical products through stronger regulatory systems abroad
著者
書誌事項
Ensuring safe foods and medical products through stronger regulatory systems abroad
National Academies Press, c2012
- : pbk
大学図書館所蔵 全1件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references
"Committee on Strengthening Core Elements of Food and Drug Regulatory Systems in Developing Countries, Board on Global Health and the Board on Health Science Policy, Institute of Medicine of the National Academies"--T.p.
内容説明・目次
内容説明
A very high portion of the seafood we eat comes from abroad, mainly from China and Southeast Asia, and most of the active ingredients in medicines we take originate in other countries. Many low- and middle-income countries have lower labor costs and fewer and less stringent environmental regulations than the United States, making them attractive places to produce food and chemical ingredients for export. Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad explains that the diversity and scale of imports makes it impractical for U.S. Food and Drug Administration (FDA) border inspections to be sufficient to ensure product purity and safety, and incidents such as American deaths due to adulterated heparin imported from China propelled the problem into public awareness.
The Institute of Medicine Committee on Strengthening Core Elements of Regulatory Systems in Developing Countries took up the vital task of helping the FDA to cope with the reality that so much of the food, drugs, biologics, and medical products consumed in the United States originate in countries with less-robust regulatory systems. Ensuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad describes the ways the United States can help strengthen regulatory systems in low and middle income countries and promote cross-border partnerships - including government, industry, and academia - to foster regulatory science and build a core of regulatory professionals. This report also emphasizes an array of practical approaches to ensure sound regulatory practices in today's interconnected world.
Table of Contents
Front Matter
Summary
1 Introduction
2 Core Elements of Regulatory Systems
3 Critical Issues
4 A Strategy to Building Food and Medical Product Regulatory
Systems
5 International Action
6 Domestic Action
7 Conclusions and Priorities
Appendix A: Glossary
Appendix B: A Review of Tort Liability's Role in Food and Medical
Product Regulation
Appendix C: Food and Medical Product Regulatory Systems of South
Africa, Brazil, India, and China
Appendix D: Chinese Food Regulatory System
Appendix E: Meeting Agendas
Appendix F: Committee Member Biographies
Appendix G: Analyzing Food Safety Alerts in European Union Rapid
Alerts Systems for Food and Feed
Appendix H: Strengthening Core Elements of Regulatory Systems in
Developing Countries: Identifying Priorities and an Appropriate
Role for the U.S. Food and Drug Administration
目次
- 1 Front Matter
- 2 Summary
- 3 1 Introduction
- 4 2 Core Elements of Regulatory Systems
- 5 3 Critical Issues
- 6 4 A Strategy to Building Food and Medical Product Regulatory Systems
- 7 5 International Action
- 8 6 Domestic Action
- 9 7 Conclusions and Priorities
- 10 Appendix A: Glossary
- 11 Appendix B: A Review of Tort Liability's Role in Food and Medical Product Regulation
- 12 Appendix C: Food and Medical Product Regulatory Systems of South Africa, Brazil, India, and China
- 13 Appendix D: Chinese Food Regulatory System
- 14 Appendix E: Meeting Agendas
- 15 Appendix F: Committee Member Biographies
- 16 Appendix G: Analyzing Food Safety Alerts in European Union Rapid Alerts Systems for Food and Feed
- 17 Appendix H: Strengthening Core Elements of Regulatory Systems in Developing Countries: Identifying Priorities and an Appropriate Role for the U.S. Food and Drug Administration
「Nielsen BookData」 より